UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

Journal of hepatology, 2017-03, Vol.66 (3), p.485-493

2017

Volltextzugriff (PDF)

Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.240-247

2013

Volltextzugriff (PDF)

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122

Journal of viral hepatitis, 2013-03, Vol.20 (3), p.158-166

2013

Volltextzugriff (PDF)

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

The lancet. Gastroenterology & hepatology, 2023-10, Vol.8 (10), p.879-907

2023

Volltextzugriff (PDF)

Randomised clinical trial: anti‐viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (4), p.443-453

2011

Volltextzugriff (PDF)

The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection

Journal of viral hepatitis, 2014-08, Vol.21 (8), p.568-577

2014

Volltextzugriff (PDF)

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C

Alimentary pharmacology & therapeutics, 2011-12, Vol.34 (11‐12), p.1306-1317

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

Value in health, 2015-11, Vol.18 (7), p.A588-A588

2015

Volltextzugriff (PDF)

Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands

Value in health, 2015-11, Vol.18 (7), p.A586-A586

2015

Volltextzugriff (PDF)

PIN71 - Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

Value in health, 2015-11, Vol.18 (7), p.A588-A588

2015

Volltextzugriff (PDF)

PIN58 - Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands

Value in health, 2015-11, Vol.18 (7), p.A586-A586

2015

Volltextzugriff (PDF)

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial

Journal of hepatology, 2005-10, Vol.43 (4), p.630-636

2005

Volltextzugriff (PDF)

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up

Journal of viral hepatitis, 2013-04, Vol.20 (4), p.e78-e81

2013

Volltextzugriff (PDF)

Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

Clinical and experimental gastroenterology, 2017-01, Vol.10, p.203-209

2017

Volltextzugriff (PDF)

Point shear wave elastography is comparable to transient elastography for the assessment of liver fibrosis in patients with chronic hepatitis B or C infection

Ultraschall in der Medizin, 2016, Vol.37 (S 01)

2016

Volltextzugriff (PDF)

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor

Journal of viral hepatitis, 2013-11, Vol.20 (11), p.779-789

2013

Volltextzugriff (PDF)

Psychiatric Side Effects and Fluctuations in Serotonergic Parameters in the Treatment of Chronic Hepatitis C Infection

Neuropsychobiology, 2012-04, Vol.65 (3), p.126-132

2012

Volltextzugriff (PDF)

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non‐invasive assessment of liver fibrosis using transient elastography

Journal of thrombosis and haemostasis, 2007-01, Vol.5 (1), p.25-30

2007

Volltextzugriff (PDF)

Acoustic Radiation Force Impulse-Imaging zur nicht-invasive Beurteilung des Leberfibrosestadiums bei chronischer Hepatitis B

Ultraschall in der Medizin, 2012-08, Vol.33 (S 02)

2012

Volltextzugriff (PDF)

Safety and antiviral activity of JTK-652: a novel HCV infection inhibitor

Antiviral therapy, 2010-01, Vol.15 (5), p.765-773

2010

Volltextzugriff (PDF)

Long‐term effect of treatment of acute Budd‐Chiari syndrome with a transjugular intrahepatic portosytemic shunt

Hepatology (Baltimore, Md.), 2002-06, Vol.35 (6), p.1551-1552

2002

Volltextzugriff (PDF)

Non-Alcoholic Steatohepatitis: Clinical Significance and Pathogenesis

Scandinavian journal of gastroenterology, 2001, Vol.36 (234), p.88-92

Knegt, R. J. De

2001

Volltextzugriff (PDF)

Viral kinetics in patients with hepatitis C genotype 1, treated with high-dose daily interferon, high-dose pegylated interferon and pegylated interferon combined with daily interferon

European journal of gastroenterology & hepatology, 2006-01, Vol.18 (1), p.A59-A60

2006

Volltextzugriff (PDF)

Non-invasive assessment of liver fibrosis in patients with hepatitis B and C. The first Dutch experience

European journal of gastroenterology & hepatology, 2006-01, Vol.18 (1), p.A59

2006

Volltextzugriff (PDF)

Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C

Alimentary pharmacology & therapeutics, 2005-03, Vol.21 (5), p.539-547

2005

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(50)
Tagungsberichte
(2)

Sprache

Englisch
(51)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(41)
Science & Technology
(41)
Humans
(33)
Gastroenterology & Hepatology
(19)
Middle Aged
(19)
Female
(18)
Adult
(17)
Male
(17)
Biological And Medical Sciences
(15)
Medical Sciences
(14)
Aged
(11)
Hepatitis C, Chronic - Drug Therapy
(10)
Infectious Diseases
(10)
Otorhinolaryngology
(9)
Antiviral Agents - Therapeutic Use
(8)
Hepatitis C Virus
(7)
Neck
(7)
Ultrasonography
(7)
Adolescent
(6)
Animals
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis B

Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

Randomised clinical trial: anti‐viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV

The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C

Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands

PIN71 - Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

PIN58 - Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands

Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: Results of a pilot randomized controlled clinical trial

Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up

Serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) predict severity of liver disease in chronic hepatitis B

Point shear wave elastography is comparable to transient elastography for the assessment of liver fibrosis in patients with chronic hepatitis B or C infection

Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor

Psychiatric Side Effects and Fluctuations in Serotonergic Parameters in the Treatment of Chronic Hepatitis C Infection

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non‐invasive assessment of liver fibrosis using transient elastography

Acoustic Radiation Force Impulse-Imaging zur nicht-invasive Beurteilung des Leberfibrosestadiums bei chronischer Hepatitis B

Safety and antiviral activity of JTK-652: a novel HCV infection inhibitor

Long‐term effect of treatment of acute Budd‐Chiari syndrome with a transjugular intrahepatic portosytemic shunt

Non-Alcoholic Steatohepatitis: Clinical Significance and Pathogenesis

Viral kinetics in patients with hepatitis C genotype 1, treated with high-dose daily interferon, high-dose pegylated interferon and pegylated interferon combined with daily interferon

Non-invasive assessment of liver fibrosis in patients with hepatitis B and C. The first Dutch experience

Dynamic decision analysis to determine optimal treatment duration in chronic hepatitis C

Suchergebnisse filtern